Percutaneous Trans-facet Spine Fixation
Launched by MAHMOUD MASSOUD · May 24, 2025
Trial Information
Current as of September 11, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is testing a minimally invasive spine surgery called Percutaneous Trans-Facet Fixation using the Massoud-Goel Technique for people with degenerative spine disease that has caused instability. It is an interventional, single-group trial that plans to enroll about 77 participants at a Cairo, Egypt hospital. Eligible people can include children, adults, and older adults who have signs of spinal instability from degeneration—such as nerve or leg/arm pain, bone spurs, reduced space between spinal bones, disc problems, or thickened ligaments near the spine on imaging. Exclusion criteria include severe cauda equina symptoms, progressive weakness, prior failed stabilization, or certain spine misalignments. The study is currently enrolling by invitation.
If you join, you would have a percutaneous (minimally invasive) facet-screw fixation procedure guided by imaging, aimed at stabilizing the affected spinal segment while preserving movement and reducing tissue disruption. Before surgery, MRI and CT scans help plan the operation. Afterward, you’d follow a structured recovery plan with pain management and physical therapy. The main result they’ll look at is pain relief at 3 months. They’ll also assess functional recovery at 3 months, and longer-term outcomes such as how well the spine fuses and complication rates at 1 year, spine stability at 6 months by CT, and MRI follow-up to monitor canal size and degeneration. The trial has no control group for comparison, results are not yet available, and researchers may share de-identified data after results are published.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • For Lumbar Sub-axial cervical instability Clinical radicular symptoms can indicate the level of spinal instability. The presence of osteophytes. Reduction of the intervertebral disc space. Disc prolapse. Ligamentum flavum buckling. For atlantoaxial instability Cervical myelopathy clinical Alteration of atlantodental interval on dynamic flexion-extension images.
- Exclusion Criteria:
- • 1. Cauda equine syndrome
- • 2. Progressive motor weakness
- • 3. Failed damage control method
- • 4. Spondylolisthesis, Spondyolysis.
About Mahmoud Massoud
Mahmoud Massoud is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, Mahmoud Massoud oversees the design, implementation, and management of clinical trials across various therapeutic areas. His expertise in regulatory compliance, patient safety, and data integrity ensures that all trials adhere to the highest ethical standards and scientific rigor. By fostering collaboration among multidisciplinary teams, Mahmoud Massoud strives to accelerate the development of groundbreaking treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Shorouk, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported